SEC Info uses JavaScript! To view pages properly, enable JavaScript in your browser.
On: Wednesday, 5/31/23, at 6:49am ET · For: 12/31/22 · Rule: 13p-1 · Item: 1.01 · Item: 1.02 · Accession #: 721371-23-32 · File #: 1-11373
Text Wildcards: ? (any letter/digit) , * (many) . Search Logic: for Documents: & (and ) , | (or) ; for Text: | (anywhere ) , "(&)" (near) . Details...
Specialized Disclosure Report re: the Use of Conflict Minerals — Form SD — Rule 13p-1 — § 1502 – DFA’10 Filing Table of Contents
Document/Exhibit Description Pages Size
1: SD Specialized Disclosure Report re: the Use of HTML 17K
Conflict Minerals
2: EX-1.01 Conflict Minerals Report HTML 57K
‘SD’ — Specialized Disclosure Report re: the Use of Conflict Minerals
This is an HTML Document rendered as filed. [ Alternative Formats ]
<!
C:
C:
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM SD
Specialized Disclosure Report
Cardinal Health, Inc.
(Exact name of registrant as specified in its charter)
Ohio 1-11373 (State
or other jurisdiction of incorporation) (Commission file number)
(Address of principal executive offices) (Zip code)
Chief Legal and Compliance Officer
(Name and telephone number, including area code, of the
person to contact in connection with this report.)
Check the appropriate box to indicate the rule pursuant to which this form is being filed:
þ Rule 13p-1 under the Securities Exchange Act (17 CFR 204.13p-1) for the reporting period from January 1 to December 31, 2022 . ☐ Rule 13q-1 under the Securities Exchange
Act (17 CFR 204.13q-1) for the fiscal year ended ___________.
Section 1 - Conflict Minerals Disclosure
Item 1.01. Conflict Minerals Disclosure and Report
Conflict Minerals Disclosure
Item 1.02. Exhibit
A copy of the Conflict Minerals Report is attached hereto as Exhibit 1.01 and incorporated herein by this reference.
Section 2
- Resource Extraction Issuer Disclosure
Item 2.01. Resource Extraction Issuer Disclosure and Report
Not applicable.
Section 3 - Exhibits
Item 3.01. Exhibits
Exhibit No. Description 1.01
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.
Dates Referenced Herein and Documents Incorporated by Reference
This ‘SD’ Filing Date Other Filings Filed on: 5/31/23 For Period end: 12/31/22 10-Q 1/1/22 List all Filings
↑ Top Filing Submission 0000721371-23-000032 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.About — Privacy — Redactions — Help —
Thu., Apr. 25, 9:18:49.1pm ET